Corebridge Financial Inc. has slightly lowered its stake in Ingevity Corporation, selling 372 shares during the first quarter. The investment firm now holds 19,016 shares of the NYSE-listed specialty chemicals producer, according to its recent filing with the Securities and Exchange Commission.
Corebridge Financial Inc. Trims Stake in Ingevity Corporation $NGVT
Key Takeaways:
- Corebridge Financial’s Ingevity stake was cut by 1.9%.
- 372 shares were sold during the first quarter.
- Corebridge now holds 19,016 shares of Ingevity Corporation.
- The data comes from a filing with the SEC.
- Ingevity trades on the NYSE under the ticker NGVT.
Corebridge’s Stake Reduction
Corebridge Financial Inc. has announced a 1.9% reduction in its shares of Ingevity Corporation. The transaction took place during the first quarter, with the institutional investor selling a total of 372 shares. Following this move, Corebridge’s total holdings stand at 19,016 shares.
SEC Filing Confirmation
Details of this stake reduction were published in the company’s most recent disclosure with the Securities and Exchange Commission (SEC). Such filings provide transparency for shareholders and the larger market, offering insight into how institutional investors adjust their portfolios over time.
Ingevity Corporation Profile
Ingevity Corporation, listed on the New York Stock Exchange under the ticker symbol NGVT, specializes in performance chemicals and materials. The details surrounding Corebridge’s reduction in shares highlights the evolving nature of institutional investor activity in the chemicals sector.
Implications for Investors
Although a 1.9% decrease in holdings may not signal a dramatic shift in investor confidence, it underscores the routine adjustments made by institutional investors to re-balance or strategize their portfolios. Market observers often track these filings closely to understand broader investment trends.
Looking Ahead
As Corebridge adapts its positions in various companies, filings like these serve as snapshots of continual movements in the market. While the sale of 372 shares is a relatively small slice of the company’s portfolio, it serves as another example of the intricacies inherent in institutional investment decisions.